Skip to main content
. 2021 Oct 27;22(21):11597. doi: 10.3390/ijms222111597

Figure 3.

Figure 3

The protumoral effect of SIA-CIgG and TME-IgG causes an accelerated tumor outgrowth in vivo. Treatment with RP215, anti-human IgG antibody, or CIgG-shRNA, in contrast, reduces tumor growth rates in vivo. ab: antibody, PBS: phosphate buffered saline, CIgG: cancer-derived IgG, SIA-CIgG: sialylated CIgG, TME-IgG: IgG isolated from tumor microenvironment.